药学名家讲座第136期公告

江苏省现代药物领域研究生创新与学术交流中心

2018年中国药科大学研究生培养创新学术活动

药学名家讲座136

讲座题目:Development of PCBP2 siRNA Nanocomplex for the Treatment of Alcoholic Liver Fibrosis

讲座时间: 201867日(周四)早930-1100

讲座地点:中国药科大学玄武校区学术交流中心307报告厅

主讲人Dr. Kun Cheng Professor of Pharmaceutical Sciences in University of Missouri-Kansas City

主持人尹莉芳教授中国药科大学药学院副院长

举办单位:中国药科大学研究生院、药学院

江苏省现代药物领域研究生创新与学术交流中心

聆听名师讲座启迪学术智慧拓宽创新视野

欢迎各位老师和同学们踊跃参加!

附 主讲人简介

Dr. Kun Cheng is Professor of Pharmaceutical Sciences in the School of Pharmacy at the University of Missouri-Kansas City (UMKC).Dr. Cheng received his B.S./M.S. from China Pharmaceutical University (1996/1999) and another M.S. from Nationa University of Singaprore (2001). He was a research scientist at the Brightfuture Pharmaceutical Company in Hong Kong prior to joining the University of Tennessee Health Science Center, where he received his Ph.D. in Pharmaceutical Sciences (2007). He joined UMKC as an Assistant Professor and was promoted to Associate Professor with tenure in 2013 and to Full Professor in 2017.

Dr. Cheng’s research focuses on the development of novel drug delivery systems for small-molecule and macromolecular drugs; identification of artificial ligands for targeted drug delivery and tumor imaging; development of peptide-modified prodrugs for chemotherapy; development of novel immunotherapy; and therapeutic applications of siRNA for the treatment of breast cancer, prostate cancer, and liver fibrosis. His research has been continuously supported by the Department of Defense (DoD), the National Institutes of Health (NIH), American Cancer Society (ACS), and the American Association of Pharmaceutical Scientists (AAPS). He is a grant reviewer for various study sections at NIH, DOD and other agencies.

Dr. Cheng is the recipient of the 2011 AAPS New Investigator Grant Award in Pharmaceutics and Pharmaceutical Technology. He is also the recipient of the UMKC Chancellor’s Early Career Award for Excellence in Teaching and the UMKC Trustees Faculty Scholar Award in 2013. He received the American Cancer Society (ACS) Research Scholar Grant Award in 2015 to support his siRNA research for breast cancer therapy. Dr. Cheng has been actively engaged in extramural professional activities. He has edited two theme issues for Molecular Pharmaceutics and Pharmaceutical Research as a guest editor. He has also edited two books entitled “Advanced Delivery and Therapeutic Applications of RNAi” and “Advanced Drug Delivery” for Wiley.